GNRX
VanEck Vectors Generic Drugs ETF
GNRX
GNRX
Delisted
GNRX was delisted on the 4th of April, 2019.
1 hedge funds and large institutions have $172K invested in VanEck Vectors Generic Drugs ETF in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$24K |
| 2 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$9.04K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
APA
1
American Portfolios Advisors
Holbrook,
New York
| $172K | -$9.04K | -362 | -5% |
|
|
2
Bank of America
Charlotte,
North Carolina
| – | -$24K | -1,000 | Closed |
|